Skip to content
Open access · CC-BY via OpenAlex

Disrupting the key circadian regulator CLOCK leads to age-dependent cardiovascular disease

Faisal J. Alibhai, Jonathan LaMarre, Cristine J. Reitz, Elena V. Tsimakouridze, Jeffrey Thomas Kroetsch, Steffen‐Sebastian Bolz, Alex Shulman, Samantha Steinberg, Thomas P. Burris, Gavin Y. Oudit, Tami A. Martino

Journal of Molecular and Cellular Cardiology · 2017 · ▲ 123 citations

Abstract

The circadian mechanism underlies daily rhythms in cardiovascular physiology and rhythm disruption is a major risk factor for heart disease and worse outcomes. However, the role of circadian rhythms is generally clinically unappreciated. Clock is a core component of the circadian mechanism and here we examine the role of Clock as a vital determinant of cardiac physiology and pathophysiology in aging. Clock Δ19/Δ19 mice develop age-dependent increases in heart weight, hypertrophy, dilation, impaired contractility, and reduced myogenic responsiveness. Young Clock Δ19/Δ19 hearts express dysregulated mRNAs and miRNAs in the PTEN-AKT signal pathways important for cardiac hypertrophy. We found a rhythm in the Pten gene and PTEN protein in WT hearts; rhythmic oscillations are lost in Clock Δ19/Δ19 hearts. Changes in PTEN are associated with reduced AKT activation and changes in downstream mediators GSK-3β, PRAS40, and S6K1. Cardiomyocyte cultures confirm that Clock regulates the AKT signalling pathways crucial for cardiac hypertrophy. In old Clock Δ19/Δ19 mice cardiac AKT, GSK3β, S6K1 phosphorylation are increased, consistent with the development of age-dependent cardiac hypertrophy. Lastly, we show that pharmacological modulation of the circadian mechanism with the REV-ERB agonist SR9009 reduces AKT activation and heart weight in old WT mice. Furthermore, SR9009 attenuates cardiac hypertrophy in mice subjected to transverse aortic constriction (TAC), supporting that the circadian mechanism plays an important role in regulating cardiac growth. These findings demonstrate a crucial role for Clock in growth and renewal; disrupting Clock leads to age-dependent cardiomyopathy. Pharmacological targeting of the circadian mechanism provides a new opportunity for treating heart disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.yjmcc.2017.01.008
Canonical
link ↗
Fetched
2026-10-25 MST

Cite this

APA
Alibhai, F.J., LaMarre, J., Reitz, C.J., Tsimakouridze, E.V., Kroetsch, J.T., Bolz, S., Shulman, A., Steinberg, S., Burris, T.P., Oudit, G.Y., &amp; Martino, T.A. (2017). Disrupting the key circadian regulator CLOCK leads to age-dependent cardiovascular disease. <em>Journal of Molecular and Cellular Cardiology</em>. https://doi.org/10.1016/j.yjmcc.2017.01.008
Vancouver
Alibhai FJ, LaMarre J, Reitz CJ, Tsimakouridze EV, Kroetsch JT, Bolz S, et al. Disrupting the key circadian regulator CLOCK leads to age-dependent cardiovascular disease. Journal of Molecular and Cellular Cardiology. 2017. doi:10.1016/j.yjmcc.2017.01.008.
BibTeX
@article{faisal2017Disrup, title = {Disrupting the key circadian regulator CLOCK leads to age-dependent cardiovascular disease}, author = {Faisal J. Alibhai and Jonathan LaMarre and Cristine J. Reitz and Elena V. Tsimakouridze and Jeffrey Thomas Kroetsch and Steffen‐Sebastian Bolz and Alex Shulman and Samantha Steinberg and Thomas P. Burris and Gavin Y. Oudit and Tami A. Martino}, journal = {Journal of Molecular and Cellular Cardiology}, year = {2017}, doi = {10.1016/j.yjmcc.2017.01.008}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings